Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus and Methotrexate in Relapsed/Refractory ALL and NHL
NCT01162551Phase 2Completed
- Sponsor
- Children's Hospital of Philadelphia
- Start
- May 2010
- Primary completion
- Feb 2017
- Countries
- 1
01
Overview
Phase 2, open-label trial of sirolimus in acute lymphoblastic leukemia (ALL) and non-Hodgkin lymphoma (NHL), sponsored by Children's Hospital of Philadelphia. Started May 2010; status: completed.
02
Drugs
sirolimus
03
Conditions
acute lymphoblastic leukemia (ALL)non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT01162551.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01162551.